OKYO OKYO Pharma Inc: Net earnings per share growth forecast for next year

Corporate company logo of OKYO Pharma Limited (OKYO)

International patent protection is critical for OKYO Pharma Limited (OKYO) due to geopolitical risks associated with drug registration. The brand's success relies on the launch of anti-inflammatory drops for patients with "dry eye," and analyst expectations for N+1 profit dynamics on GURU.Markets indicate that the metric level is -200.50. Currently, OKYO Pharma Limited (OKYO) is systematically spending investor capital on clinical trials in the complete absence of revenue.

OKYO Pharma Limited (OKYO): Earnings growth forecast for next year from 06/27/2023 to 11/17/2026

Metric breakdowns and analytics for OKYO Pharma Limited (OKYO)

- price and consensus price forecast:
- company stock capitalization data:
Fundamental company valuation:OKYO, okyopharma.com
Core merchandise of OKYO Pharma Inc

This indicator measures the consensus earnings forecast for the upcoming period, isolating the long-term fundamental trend from market noise. The current value of -200.50 in the next year's EPS projections for OKYO Pharma Limited (OKYO) reflects market expectations regarding the commercialization of the OK-101 drug for the therapy of neuropathic pain. The positive trajectory of this metric signals capital's readiness to invest in a unique non-hormonal treatment mechanism for ophthalmological pathologies.

Who OKYO Pharma Limited competes with

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Apellis Pharmaceuticals, Inc. (APLS)|Earnings growth forecast for next year BLTE (Belite Bio)|OCUL - Expected earnings per share growth for next year|HROW - Net earnings per share growth forecast for next year|Expected earnings per share trend next year VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Expected earnings per share growth for next year|Oculis Holding AG - Expected earnings per share trend next year|Net earnings per share growth forecast for next year eyepointpharma.com|Earnings growth forecast for next year Kodiak Sciences Inc.|Net earnings per share growth forecast for next year Aldeyra Therapeutics Inc. (ALDX)|Net earnings per share growth forecast for next year KALA (KALA BIO)|Net earnings per share growth forecast for next year opusgtx.com IRD|ADVM - Expected earnings per share growth for next year|OTLK: Expected earnings per share growth for next year|CLSD (Clearside) - Projected earnings per share growth rate for next year|NBY: Earnings growth forecast for next year|Kiora Pharma (KPRX) - Earnings growth forecast for next year|ALIM (alimerasciences.com) - Earnings growth forecast for next year|eyenovia.com (EYEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)